MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Guardant Health Inc

Cerrado

SectorSalud

65.54 3.36

Resumen

Variación precio

24h

Actual

Mínimo

63.43

Máximo

65.96

Métricas clave

By Trading Economics

Ingresos

-4.7M

-100M

Ventas

29M

232M

Margen de beneficio

-43.044

Empleados

1,999

EBITDA

22M

-89M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+9.32% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

2.4B

7.9B

Apertura anterior

62.18

Cierre anterior

65.54

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

Guardant Health Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

8 oct 2025, 20:45 UTC

Ganancias

Costco Wholesale Sales Climb in September, Early October

8 oct 2025, 20:12 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

TaskUs Shares Fall After Holders Reject Take-Private Deal

8 oct 2025, 16:39 UTC

Principales Movimientos del Mercado

Mining Shares Rise as Gold Prices Soar

8 oct 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 oct 2025, 23:43 UTC

Charlas de Mercado

Gold Falls on Possible Profit-Taking -- Market Talk

8 oct 2025, 23:18 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Finance Acquisition Using Internal Funds

8 oct 2025, 23:17 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Buy On-Demand Delivery Services Business for US$270.0M

8 oct 2025, 23:16 UTC

Adquisiciones, fusiones, absorciones

JD Logistics to Buy JD.com's On-Demand Delivery Services Business Dajiang and Dasheng

8 oct 2025, 21:54 UTC

Charlas de Mercado
Ganancias

James Hardie Could Beat Annual Earnings Goal -- Market Talk

8 oct 2025, 21:30 UTC

Charlas de Mercado

Boab Metals Bull Delivers Second Upgrade in a Month -- Market Talk

8 oct 2025, 21:26 UTC

Charlas de Mercado
Ganancias

Transurban's 1Q Traffic Growth Beats Hopes -- Market Talk

8 oct 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 oct 2025, 19:15 UTC

Charlas de Mercado

Geopolitical Risk Supports Gains in Oil Futures -- Market Talk

8 oct 2025, 19:01 UTC

Charlas de Mercado

U.S. Natural Gas Futures Pull Back Ahead of Storage Data -- Market Talk

8 oct 2025, 18:47 UTC

Charlas de Mercado

Coca-Cola North America Sales Buoy International Weakness -- Market Talk

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs: Neither Party Will Be Required to Pay Termination Fee as Result of Planned Mutual Decision to Terminate

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs Will Remain a Publicly Traded Co >TASK

8 oct 2025, 18:46 UTC

Adquisiciones, fusiones, absorciones

TaskUs Does Not Plan to Convene Another Special Meeting of Stockholders >TASK

8 oct 2025, 18:45 UTC

Adquisiciones, fusiones, absorciones

TaskUs Didn't Receive Votes Necessary to Approve Transaction Agreement With Affil of Blackstone >TASK

8 oct 2025, 18:07 UTC

Charlas de Mercado

Mexico's Inflation Seen Edging Up in September -- Market Talk

8 oct 2025, 16:20 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Energy & Utilities Roundup: Market Talk

8 oct 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 oct 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 oct 2025, 15:57 UTC

Charlas de Mercado

Oil Rises Despite U.S. Crude Stockpiles Build -- Market Talk

8 oct 2025, 15:56 UTC

Charlas de Mercado

Teck Resources' Chile Mine Issues Appear Transitory -- Market Talk

8 oct 2025, 15:53 UTC

Charlas de Mercado

Argentine Sovereign Debt Seen as Attractive -- Market Talk

8 oct 2025, 15:44 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical: Broadwood's Proposal to Vote Down Merger Could Allow It to Take Control Without Paying Any Premium

8 oct 2025, 15:44 UTC

Adquisiciones, fusiones, absorciones

Staar Surgical Board and Management Disagree With Recommendation Issued by Glass Lewis >STAA

8 oct 2025, 15:43 UTC

Adquisiciones, fusiones, absorciones

STAAR Surgical Board Reiterates Unanimous Recommendation Holders Vote for Alcon Merger

8 oct 2025, 15:42 UTC

Adquisiciones, fusiones, absorciones

Oracle Is a Buy-the-Dip Opportunity, Analyst Says. How the Stock Could Rise 23%. -- Barrons.com

Comparación entre iguales

Cambio de precio

Guardant Health Inc Esperado

Precio Objetivo

By TipRanks

9.32% repunte

Estimación a 12 meses

Media 69.35 USD  9.32%

Máximo 80 USD

Mínimo 60 USD

De acuerdo con 22 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Guardant Health Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

22 ratings

21

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

38.86 / 47.41Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bullish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat